<?xml version="1.0" encoding="UTF-8"?>
<p>Participants raised further concerns over the safety of the influenza vaccine with regards to its content and periodic manufacturing. This corroborates the SAGE Working Group’s Vaccine Hesitancy Determinants Matrix, in which the introduction of new formulation or new recommendations for existing vaccines was identified to influence hesitancy [
 <xref rid="pone.0232472.ref052" ref-type="bibr">52</xref>]. Participants’ concerns may be alleviated with communication about vaccine safety (i.e., does not contain germs or zoonotic viruses) from multiple points such as the local government, health organizations, and health practitioners. More comprehensible explanations are necessary to instill knowledge about the mutability of influenza viruses and the need for vaccine manufacturers to produce new vaccines every year to protect users from circulating mutated influenza strains.
</p>
